Where does Flow Neuroscience, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Flow Neuroscience, Inc. ranks #24,347 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Flow Neuroscience, Inc. hold?

Flow Neuroscience, Inc. holds 11 US utility patents granted between 2021 and 2025, spanning 2 technology areas.

What is Flow Neuroscience, Inc.'s Innovation Score?

Flow Neuroscience, Inc. has an Innovation Score of 35.6 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Flow Neuroscience, Inc. focus on?

Flow Neuroscience, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 11 patents, ranking #336 of 1,943 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

Is Flow Neuroscience, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Flow Neuroscience, Inc..

What does claim depth mean for Flow Neuroscience, Inc.'s patents?

Flow Neuroscience, Inc.'s patents average 20.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Flow Neuroscience, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Flow Neuroscience, Inc.

USPTO PatentsView assignee record - 11 granted patents across 2 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Flow ranks #24,347 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 2 technology areas.

#24,347
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.6/100): 20.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R24347 · US Corporation #24,347 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #24,347/49,997
PHOTO-FINISH Flo
CPC-NARROW A61N · 2 areas
INNOV-THIN 35.6/100
CLAIMS-DENSE 20.1 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Flo Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Flow’s 35.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (24%) Velocity 10.0 pts (28%) Breadth 5.0 pts (14%) Claim depth 12.1 pts (34%)

Qualcomm Incorporated · highest

85
Flow Neuroscience · this assignee

36
Handstands Promo · near

36
NovoMedix · near

36
Saitama Medical… · near

36
Shenzhen Yunyinggu… · near

36
3D Lighting… · lowest

7

What this shows Flow's Innovation Score is 35.6/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Flow?

Each dot is one of Flow’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Flow’s own 20.1 claims/patent is ABOVE the 10.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Flow vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Flow's grants concentrate

Flow Neuroscience, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2021 (4 grants) versus a trough of 2 in 2022. By volume, Flow sits between Flo Technologies, Inc. and Fonality, Inc..

Flow's three-year grant acceleration

Flow Neuroscience, Inc. shows 6 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Flo

11
Flospine

11
Floreac div Micro…

11
Florence

11
Fluehs Drehtechnik

11
Fluke Precision M…

11
Follett

11
Fonality

11
Flow Neuroscience ◀

11

What this shows Flow holds 11 patents at rank #24,355, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Flow

By rank, the assignees closest to #24,355 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Flow's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Flow, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Flow ranks #336 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Handstands Promo, LLC 36 Shenzhen Yunyinggu Technology Co., Ltd. 36 Saitama Medical University 36 NovoMedix, LLC 36

Flow's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Flow Neuroscience, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	4	36.4%
2022	2	18.2%
2024	4	36.4%
2025partial year	1	9.1%

Which technologies does Flow Neuroscience, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 11

A61B - DIAGNOSIS; SURGERY; Identification 9

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Flow Neuroscience, Inc.'s patent record in context - here's where to go next.

Flow Neuroscience, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #24,347 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Flow Neuroscience, Inc. against Flo Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.